BG Medicine, Inc. BG Medicine, Inc.

BG Medicine, Inc.

BGMD

Rank in Stocks #34940
BG Medicine, Inc. is dedicated to the development and commercialization of... BG Medicine, Inc. is dedicated to the development and commercialization of diagnostic products aimed at guiding patient care for individuals in the United States afflicted with heart failure and related conditions. Its product portfolio includes the BGM Galectin-3 Test, an in vitro diagnostic solution that quantifies galectin-3 levels in blood serum or plasma using an enzyme-linked immunosorbent assay (ELISA) on a microtiter plate platform. Additionally, the company provides the CardioSCORE Test, a multi-analyte, biomarker-based blood test designed to assess the short-term risk of atherothrombotic cardiovascular events, such as myocardial infarction (heart attack) and ischemic stroke. BG Medicine maintains licensing, development, and commercialization agreements with major partners like Abbott Laboratories, bioMérieux SA, Siemens Healthcare Diagnostics Inc., and Alere Inc., specifically for automated versions of its galectin-3 test. Furthermore, it has forged a strategic alliance with Abbott Laboratories to jointly develop and market galectin-3 assay kits, along with their corresponding control kits and calibrators. Founded in 2000, the company was initially known as Beyond Genomics, Inc., before rebranding to BG Medicine, Inc. in October 2004. Its corporate headquarters are located in Waltham, Massachusetts.
Share Price
$0.0001
Last synced: 2026-11-13
Market Cap
$1.13K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country

Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this

Category

Healthcare
EPS for BG Medicine, Inc. (BGMD)
EPS as of December 2015 TTM: $-0.57
According to BG Medicine, Inc.'s latest financial reports, its current EPS (TTM) is $-0.57. At the end of 2015 the company had an EPS of $-0.55, an increase over its 2014 EPS of $-0.99.
EPS history for BG Medicine, Inc. from 2004 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-0.57 3.64%
2015 $-0.55 -44.44%
2014 $-0.99 -57.51%
2013 $-2.33 -50.43%
2012 $-4.70 17.79%
2011 $-3.99 -82.73%
2010 $-23.10 4.90%
2009 $-22.02 8.53%
2008 $-20.29 218.03%
2006 $-6.38 -42.42%
2005 $-11.08 218.39%
2004 $-3.48 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$8.37 -1,568.42%
US
$5.95 -1,144.33%
FR
$4.15 -828.07%
US
$5.26 -1,022.70%
JP
$1.34 -335.09%
CH

Questions about BG Medicine, Inc.'s earnings per share (EPS)

What is BG Medicine, Inc.'s earnings per share (EPS)?

BG Medicine, Inc.'s earnings per share (EPS) over the last twelve months is $-0.57, as of Dec 2015.

What was BG Medicine, Inc.'s earnings per share (EPS) in 2015?

In 2015, BG Medicine, Inc.'s earnings per share (EPS) was $-0.55, compared with $-0.99 in 2014.

How has BG Medicine, Inc.'s earnings per share (EPS) changed since 2010?

From 2010 to 2015, BG Medicine, Inc.'s earnings per share (EPS) was highest in 2015 ($-0.55) and lowest in 2010 ($-23.10).

How does BG Medicine, Inc.'s earnings per share (EPS) compare with similar companies?

BG Medicine, Inc.'s earnings per share (EPS) ($-0.57) is lower than that of all 5 similar companies listed above. The highest among them is Intuitive Surgical, Inc., with $8.37.